The Gross Margin of Mithra Pharmaceuticals SA (MITRA.BR) is 45.34%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 45.34% |
| 2022-12-31 | 70.71% |
| 2021-12-31 | 30.63% |
| 2020-12-31 | 61.72% |
| 2019-12-31 | 97.42% |
| 2018-12-31 | 97.29% |
| 2017-12-31 | 91.90% |
| 2016-12-31 | 59.81% |
| 2015-12-31 | 50.11% |
| 2014-12-31 | 31.63% |